We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACH
1801
Accendra Health
ACH
$87.7M
$236K ﹤0.01%
30,958
NVEE
1802
DELISTED
NV5 Global
NVEE
$236K ﹤0.01%
18,544
TBI
1803
Trueblue
TBI
$303M
$235K ﹤0.01%
15,422
FSP
1804
Franklin Street Properties
FSP
$46.7M
$235K ﹤0.01%
46,236
HLX icon
1805
Helix Energy Solutions
HLX
$1.5B
$234K ﹤0.01%
67,569
CTBI icon
1806
Community Trust Bancorp
CTBI
$1.43B
$234K ﹤0.01%
7,150
CMO
1807
DELISTED
Capstead Mortgage Corp.
CMO
$234K ﹤0.01%
42,582
TPC
1808
Tutor Perini Cor
TPC
$5.06B
$234K ﹤0.01%
19,192
KRYS icon
1809
Krystal Biotech
KRYS
$9.87B
$233K ﹤0.01%
5,633
+1,124
+25% +$54.1K
AVTA
1810
DELISTED
Avantax, Inc. Common Stock
AVTA
$232K ﹤0.01%
20,338
BBT
1811
Beacon Financial Corp
BBT
$2.71B
$232K ﹤0.01%
21,074
HSII
1812
DELISTED
Heidrick & Struggles
HSII
$232K ﹤0.01%
10,726
+3,469
+48% +$76.4K
SIG icon
1813
Signet Jewelers
SIG
$3.6B
$232K ﹤0.01%
22,572
ADTN icon
1814
Adtran
ADTN
$662M
$231K ﹤0.01%
21,158
+6,882
+48% +$71.1K
RILY icon
1815
BRC Group Holdings
RILY
$304M
$231K ﹤0.01%
10,620
ABTX
1816
DELISTED
Allegiance Bancshares
ABTX
$231K ﹤0.01%
9,094
THR
1817
DELISTED
Thermon Group Holdings
THR
$231K ﹤0.01%
15,847
FCEL icon
1818
FuelCell Energy
FCEL
$1.64B
$230K ﹤0.01%
+3,400
New +$210K
NGM
1819
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$230K ﹤0.01%
11,665
NIC icon
1820
Nicolet Bankshares
NIC
$3.74B
$230K ﹤0.01%
4,200
IMVT icon
1821
Immunovant
IMVT
$8.71B
$230K ﹤0.01%
+9,447
New +$202K
JOUT icon
1822
Johnson Outdoors
JOUT
$514M
$230K ﹤0.01%
2,524
MBI icon
1823
MBIA
MBI
$255M
$229K ﹤0.01%
31,645
KNSA icon
1824
Kiniksa Pharmaceuticals
KNSA
$6.1B
$229K ﹤0.01%
9,003
+1,911
+27% +$39.9K
CLVS
1825
DELISTED
Clovis Oncology, Inc.
CLVS
$229K ﹤0.01%
33,976
+12,009
+55% +$90.9K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.